New Details on the Ongoing Suboxone Tooth Decay Lawsuit

The Suboxone teeth decay lawsuit revolves around allegations that a medication called Suboxone has caused tooth decay in some patients.

This legal case is still ongoing, with new updates coming up regularly. If you’re following this case closely, our article provides the latest details and insights you need to know.

If you are someone you know has suffered from a similar problem, contact a Suboxone tooth decay attorney to help you file a case and seek compensation.

About Suboxone Teeth Decay Lawsuit

The Suboxone teeth decay lawsuit involves allegations that the medication Suboxone has led to tooth decay in some patients.

Suboxone is a treatment for people dealing with opioid addiction. The lawsuit claims that certain ingredients in Suboxone have caused dental problems such as decay and tooth loss.

Plaintiffs argue that the manufacturers of Suboxone failed to adequately warn about these potential side effects.

The First Suboxone Lawsuit – September 25, 2023

David Sorensen from Ohio was the first person to file a Suboxone lawsuit. He sued the manufacturers of the medication.

Sorensen alleges that the acidic content of Suboxone caused him permanent dental damage and tooth decay.

He filed the lawsuit on September 25, in the U.S. District Court for the Northern District of Ohio, against,

Indivior
MonoSol Rx
Aquestive Therapeutics
Reckitt Benckiser

Sorensen was prescribed Suboxone for opioid addiction after managing pain with opioids. However, he claims that he needed extensive dental work due to the medication.

The lawsuit states that the manufacturers were aware of the dental risks that come with Suboxone but failed to adequately warn users.

Previous Cases Prior to the Lawsuit

Indivior is accused of knowing about the risk of tooth decay in Suboxone users long before.

In 2010, the company submitted nearly 20 reports to the FDA detailing dental issues among Suboxone users.
In 2012, case reports from Brigham and Women’s Hospital in Boston highlighted worsening dental health in 11 patients linked to Suboxone use.
The FDA’s January 2022 warning cited over 300 cases of tooth decay and loss associated with Suboxone and buprenorphine medications.

New Details on the Suboxone Teeth Decay Lawsuit

Here are some recent updates in the Suboxone teeth decay lawsuit:

October 30, 2023

Indivior faced multiple legal challenges, including a False Claims Act lawsuit for an alleged illegal kickback scheme. Also, there were an increasing number of lawsuits alleging Suboxone usage resulted in advanced tooth decay.

November 1, 2023

Registration of fourteen new Suboxone tooth decay lawsuits against Indivior in federal courts.

November 17, 2023

Plaintiffs’ lawyers have petitioned the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all Suboxone lawsuits filed in Federal Courts nationwide into one jurisdiction. They propose the Northern District of Ohio for consolidation.

December 4, 2023

Lawyers representing plaintiffs in various federal districts who suffered dental issues from Suboxone use have filed a motion to consolidate all federal Suboxone cases into multidistrict litigation (MDL) for more efficient legal proceedings. The Northern District of Ohio is suggested for MDL due to the majority of pending cases being located there.

December 26, 2023

The Judicial Panel on Multidistrict Litigation (JPML) has scheduled a hearing for January 25, 2024, in Santa Barbara, California. It is to consider arguments from plaintiff and defense lawyers regarding the consolidation of pending Suboxone tooth decay lawsuits across Federal Courts in the United States.

January 2, 2024

Recent studies suggest a link between Suboxone use and an increased threat of tooth decay. These studies indicate that the drug alters oral bacteria balance and reduces saliva production, contributing to dental problems.

January 3, 2024

As the number of Suboxone teeth decay lawsuits continues to rise, more legal action awaits, with hundreds of potential cases under investigation nationwide. As of now, no settlement offerings are heard of in any Suboxone tooth decay lawsuits.

January 4, 2024

A woman from Cuyahoga County has filed a Suboxone teeth decay lawsuit against Indivior. Her complaint details significant tooth decay resulting from Suboxone use. Over 15 plaintiffs have taken legal action against Indivior in federal court. The parties seek consolidation of the cases into multidistrict litigation (MDL.

January 16, 2024

Lindsay Haddad, a new plaintiff joins the lawsuit. Her product liability lawsuit alleges that Indivior failed to provide essential information to the medical community for proper patient care.

January 17, 2024

Indivior, the maker of Suboxone, reportedly knew about the risk of tooth decay for users, as it was mentioned in the prescribing information for doctors. However, they did not include it in the medication guide for patients. More details about the MDL decision are to come after January 25.

January 27, 2024

In an effort to accelerate proceedings and enable potential client reimbursement, the JPML met to propose grouping all Suboxone lawsuits into a multidistrict litigation (MDL). Indivior and Reckitt-Benckiser are in favor of the consolidation.

February 2, 2024

An MDL has been created from the consolidation of federal Suboxone litigation. The Northern District of Ohio lawsuit is overseen by Judge Phillip Calabrese.

February 6, 2024

Settlement discussions may take time in the Suboxone lawsuits, as plaintiffs must provide strong scientific evidence to support their claims.

February 7, 2024

Suboxone lawsuits are gaining traction, with heavy internet advertising indicating increased awareness of the dental health risks associated with sublingual buprenorphine.

February 17, 2024

Judge Calabrese has scheduled a hearing on March 7, 2024, in Cleveland, Ohio. This hearing aims to establish a discovery calendar and expedite the lawsuit.

February 21, 2024

Prospective clients are concerned about the statute of limitations in their states affecting their ability to file a Suboxone lawsuit. Most states have a two-year statute of limitations for product liability cases based on a “failure to warn” theory. For states with a two-year limit, the deadline passed in January 2024 after Indivior added tooth decay to the warning label in January 2022. However, claims are still open in states with longer statutes of limitations, ranging from three to five years.

March 1, 2024

Two new lawsuits have been added to the Suboxone MDL. One involves a Kentucky man who started using the drug in 2011 but wasn’t warned about potential harm until 2023. The second case was filed by an Ohio man who also suffered dental issues due to Suboxone and claimed he was not warned about the drug’s risks by his doctor.

Contact Suboxone Tooth Decay Lawyer

Individuals who have experienced significant tooth decay or other oral issues due to Suboxone may be eligible for compensation. A Suboxone tooth decay lawyer can help you file a lawsuit.